2SHP - JenaLib

Asym.Unit - manually (Jmol Viewer)

Asymmetric Unit (Jmol Viewer)

Asym. Unit - sites (Jmol Viewer)

Biological Unit 1 (Jmol Viewer)

Biol. Unit 1 - sites (Jmol Viewer)

Biological Unit 2 (Jmol Viewer)

Title :   TYROSINE PHOSPHATASE SHP-2

Authors :   P. Hof, S. Pluskey, S. Dhe-Paganon, M. J. Eck, S. E. Shoelson

Date :   01 Dec 97 (Deposition) - 16 Feb 99 (Release) - 24 Feb 09 (Revision)

Method :   X-RAY DIFFRACTION

Resolution :   2.00

Chains :   Asym. Unit : A,B
Biol. Unit 1: A  (1x)
Biol. Unit 2: B  (1x)

Keywords :   Tyrosine Phosphatase, Insulin Signaling, Sh2 Protein (Keyword Search: [Gene Ontology, PubMed, Web (Google)] )

Reference :   P. Hof, S. Pluskey, S. Dhe-Paganon, M. J. Eck, S. E. Shoelson
Crystal Structure Of The Tyrosine Phosphatase Shp-2.
Cell(Cambridge, Mass. ) V. 92 441 1998
PubMed-ID: 9491886 | Reference-DOI: 10.1016/S0092-8674(00)80938-1
(for further references see the PDB file header)

Molecule 1 - SHP-2
	Chains	:	A, B
	EC Number	:	3.1.3.48
	Engineered	:	YES
	Expression System	:	ESCHERICHIA COLI
	Expression System Taxid	:	562
	Mutation	:	YES
	Organism Common	:	HUMAN
	Organism Scientific	:	HOMO SAPIENS
	Organism Taxid	:	9606
	Synonym	:	SYP, SHPTP-2

		1	2
Asymmetric Unit	:	A	B
Biological Unit 1 (1x)	:	A
Biological Unit 2 (1x)	:		B

Summary Information (see also Sequences/Alignments below)

Asymmetric Unit (1, 2)

No.	Name	Count	Type	Full Name
1	CAT	2	Ligand/Ion	DODECANE-TRIMETHYLAMINE

Biological Unit 1 (1, 1)

No.	Name	Count	Type	Full Name
1	CAT	1	Ligand/Ion	DODECANE-TRIMETHYLAMINE

Biological Unit 2 (1, 1)

No.	Name	Count	Type	Full Name
1	CAT	1	Ligand/Ion	DODECANE-TRIMETHYLAMINE

Asymmetric Unit (2, 2)

No.	Name	Evidence	Residues	Description
1	AC1	SOFTWARE	THR A:356 , PHE A:420 , TRP A:423 , PRO A:429 , VAL A:435 , PHE A:438 , PHE A:469 , ILE A:472 , SER A:513	BINDING SITE FOR RESIDUE CAT A 1800
2	AC2	SOFTWARE	THR B:356 , PHE B:420 , TRP B:423 , PRO B:429 , SER B:430 , PRO B:432 , VAL B:435 , PHE B:438 , PHE B:469 , ILE B:472 , SER B:513 , MET B:516	BINDING SITE FOR RESIDUE CAT B 2800

(no "SS Bond" information available for 2SHP)

(no "Cis Peptide Bond" information available for 2SHP)

Asymmetric Unit (60, 120)

								dbSNP	PDB
No.	Source	Variant ID	Variant			UniProt ID	Status	ID	Chain	Variant
01	UniProt	VAR_027183	T	2	I	PTN11_HUMAN	Disease (NS1)	267606990	A/B	K	2	I
02	UniProt	VAR_015601	T	42	A	PTN11_HUMAN	Disease (NS1)	397507501	A/B	T	42	A
03	UniProt	VAR_027184	N	58	K	PTN11_HUMAN	Disease (NS1)	397507506	A/B	N	58	K
04	UniProt	VAR_066060	T	59	A	PTN11_HUMAN	Disease (NS1)	---	A/B	T	59	A
05	UniProt	VAR_015602	G	60	A	PTN11_HUMAN	Disease (NS1)	397507509	A/B	G	60	A
06	UniProt	VAR_015990	G	60	V	PTN11_HUMAN	Polymorphism	397507509	A/B	G	60	V
07	UniProt	VAR_015603	D	61	G	PTN11_HUMAN	Disease (NS1)	121918461	A/B	D	61	G
08	UniProt	VAR_015604	D	61	N	PTN11_HUMAN	Disease (NS1)	397507510	A/B	D	61	N
09	UniProt	VAR_015991	D	61	V	PTN11_HUMAN	Disease (JMML)	121918461	A/B	D	61	V
10	UniProt	VAR_015992	D	61	Y	PTN11_HUMAN	Disease (JMML)	---	A/B	D	61	Y
11	UniProt	VAR_015605	Y	62	D	PTN11_HUMAN	Disease (NS1)	121918460	A/B	Y	62	D
12	UniProt	VAR_015606	Y	63	C	PTN11_HUMAN	Disease (NS1)	121918459	A/B	Y	63	C
13	UniProt	VAR_015993	E	69	K	PTN11_HUMAN	Disease (JMML)	---	A/B	E	69	K
14	UniProt	VAR_027185	E	69	Q	PTN11_HUMAN	Disease (NS1)	397507511	A/B	E	69	Q
15	UniProt	VAR_015994	F	71	K	PTN11_HUMAN	Unclassified	---	A/B	F	71	K
16	UniProt	VAR_015995	F	71	L	PTN11_HUMAN	Polymorphism	397507512	A/B	F	71	L
17	UniProt	VAR_015607	A	72	G	PTN11_HUMAN	Disease (NS1)	121918454	A/B	A	72	G
18	UniProt	VAR_015608	A	72	S	PTN11_HUMAN	Disease (NS1)	121918453	A/B	A	72	S
19	UniProt	VAR_015996	A	72	T	PTN11_HUMAN	Disease (JMML)	121918453	A/B	A	72	T
20	UniProt	VAR_015997	A	72	V	PTN11_HUMAN	Disease (JMML)	121918454	A/B	A	72	V
21	UniProt	VAR_015609	T	73	I	PTN11_HUMAN	Disease (NS1)	28933387	A/B	T	73	I
22	UniProt	VAR_015998	E	76	A	PTN11_HUMAN	Disease (JMML)	121918465	A/B	E	76	A
23	UniProt	VAR_015610	E	76	D	PTN11_HUMAN	Disease (NS1)	397507514	A/B	E	76	D
24	UniProt	VAR_015999	E	76	G	PTN11_HUMAN	Disease (JMML)	121918465	A/B	E	76	G
25	UniProt	VAR_016000	E	76	K	PTN11_HUMAN	Disease (JMML)	28933388	A/B	E	76	K
26	UniProt	VAR_016001	E	76	V	PTN11_HUMAN	Disease (JMML)	121918465	A/B	E	76	V
27	UniProt	VAR_027186	Q	79	P	PTN11_HUMAN	Disease (NS1)	---	A/B	Q	79	P
28	UniProt	VAR_015611	Q	79	R	PTN11_HUMAN	Disease (NS1)	121918466	A/B	Q	79	R
29	UniProt	VAR_015612	D	106	A	PTN11_HUMAN	Disease (NS1)	397507517	A/B	D	106	A
30	UniProt	VAR_015613	E	139	D	PTN11_HUMAN	Disease (NS1)	397507520	A/B	E	139	D
31	UniProt	VAR_027187	Q	256	R	PTN11_HUMAN	Disease (NS1)	397507523	A/B	Q	256	R
32	UniProt	VAR_078101	L	261	F	PTN11_HUMAN	Disease (NS1)	397507525	A/B	L	261	F
33	UniProt	VAR_078102	L	261	H	PTN11_HUMAN	Disease (NS1)	765642157	A/B	L	261	H
34	UniProt	VAR_078103	L	262	F	PTN11_HUMAN	Disease (NS1)	---	A/B	L	262	F
35	UniProt	VAR_078104	L	262	R	PTN11_HUMAN	Disease (NS1)	397507526	A/B	L	262	R
36	UniProt	VAR_078105	R	265	Q	PTN11_HUMAN	Disease (NS1)	376607329	A/B	R	265	Q
37	UniProt	VAR_015614	Y	279	C	PTN11_HUMAN	Disease (NS1)	121918456	A/B	Y	279	C
38	UniProt	VAR_027188	Y	279	S	PTN11_HUMAN	Disease (LPRD1)	121918456	A/B	Y	279	S
39	UniProt	VAR_015615	I	282	V	PTN11_HUMAN	Disease (NS1)	397507529	A/B	I	282	V
40	UniProt	VAR_015617	F	285	L	PTN11_HUMAN	Disease (NS1)	397507531	A/B	F	285	L
41	UniProt	VAR_015616	F	285	S	PTN11_HUMAN	Disease (NS1)	121918463	A/B	F	285	S
42	UniProt	VAR_015619	N	308	D	PTN11_HUMAN	Disease (NS1)	28933386	A/B	N	308	D
43	UniProt	VAR_015618	N	308	S	PTN11_HUMAN	Disease (NS1)	121918455	A/B	N	308	S
44	UniProt	VAR_015620	I	309	V	PTN11_HUMAN	Unclassified (NS1)	201787206	A/B	I	309	V
45	UniProt	VAR_027189	T	415	M	PTN11_HUMAN	Disease (NS1)	121918467	A/B	T	411	M
46	UniProt	VAR_027190	A	465	T	PTN11_HUMAN	Disease (LPRD1)	121918468	A/B	A	461	T
47	UniProt	VAR_027191	G	468	A	PTN11_HUMAN	Disease (LPRD1)	121918469	A/B	G	464	A
48	UniProt	VAR_015621	T	472	M	PTN11_HUMAN	Disease (LPRD1)	121918457	A/B	T	468	M
49	UniProt	VAR_071706	P	495	S	PTN11_HUMAN	Disease (NS1)	397507539	A/B	P	491	S
50	UniProt	VAR_027192	R	502	L	PTN11_HUMAN	Disease (LPRD1)	397507542	A/B	R	498	L
51	UniProt	VAR_027193	R	502	W	PTN11_HUMAN	Disease (LPRD1)	397507541	A/B	R	498	W
52	UniProt	VAR_015622	R	505	K	PTN11_HUMAN	Disease (NS1)	397507543	A/B	R	501	K
53	UniProt	VAR_015623	S	506	T	PTN11_HUMAN	Disease (NS1)	121918458	A/B	S	502	T
54	UniProt	VAR_016002	G	507	A	PTN11_HUMAN	Disease (JMML)	397507546	A/B	G	503	A
55	UniProt	VAR_016003	G	507	R	PTN11_HUMAN	Disease (NS1)	397507545	A/B	G	503	R
56	UniProt	VAR_015624	M	508	V	PTN11_HUMAN	Disease (NS1)	397507547	A/B	M	504	V
57	UniProt	VAR_027194	Q	510	P	PTN11_HUMAN	Disease (LPRD1)	397509345	A/B	Q	506	P
58	UniProt	VAR_027195	Q	510	R	PTN11_HUMAN	Disease (NS1)	---	A/B	Q	506	R
59	UniProt	VAR_076499	Q	514	E	PTN11_HUMAN	Disease (NS1)	397507549	A/B	Q	510	E
60	UniProt	VAR_027196	Q	514	P	PTN11_HUMAN	Disease (LPRD1)	121918470	A/B	Q	510	P

SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)

Biological Unit 1 (60, 60)

								dbSNP	PDB
No.	Source	Variant ID	Variant			UniProt ID	Status	ID	Chain	Variant
01	UniProt	VAR_027183	T	2	I	PTN11_HUMAN	Disease (NS1)	267606990	A	K	2	I
02	UniProt	VAR_015601	T	42	A	PTN11_HUMAN	Disease (NS1)	397507501	A	T	42	A
03	UniProt	VAR_027184	N	58	K	PTN11_HUMAN	Disease (NS1)	397507506	A	N	58	K
04	UniProt	VAR_066060	T	59	A	PTN11_HUMAN	Disease (NS1)	---	A	T	59	A
05	UniProt	VAR_015602	G	60	A	PTN11_HUMAN	Disease (NS1)	397507509	A	G	60	A
06	UniProt	VAR_015990	G	60	V	PTN11_HUMAN	Polymorphism	397507509	A	G	60	V
07	UniProt	VAR_015603	D	61	G	PTN11_HUMAN	Disease (NS1)	121918461	A	D	61	G
08	UniProt	VAR_015604	D	61	N	PTN11_HUMAN	Disease (NS1)	397507510	A	D	61	N
09	UniProt	VAR_015991	D	61	V	PTN11_HUMAN	Disease (JMML)	121918461	A	D	61	V
10	UniProt	VAR_015992	D	61	Y	PTN11_HUMAN	Disease (JMML)	---	A	D	61	Y
11	UniProt	VAR_015605	Y	62	D	PTN11_HUMAN	Disease (NS1)	121918460	A	Y	62	D
12	UniProt	VAR_015606	Y	63	C	PTN11_HUMAN	Disease (NS1)	121918459	A	Y	63	C
13	UniProt	VAR_015993	E	69	K	PTN11_HUMAN	Disease (JMML)	---	A	E	69	K
14	UniProt	VAR_027185	E	69	Q	PTN11_HUMAN	Disease (NS1)	397507511	A	E	69	Q
15	UniProt	VAR_015994	F	71	K	PTN11_HUMAN	Unclassified	---	A	F	71	K
16	UniProt	VAR_015995	F	71	L	PTN11_HUMAN	Polymorphism	397507512	A	F	71	L
17	UniProt	VAR_015607	A	72	G	PTN11_HUMAN	Disease (NS1)	121918454	A	A	72	G
18	UniProt	VAR_015608	A	72	S	PTN11_HUMAN	Disease (NS1)	121918453	A	A	72	S
19	UniProt	VAR_015996	A	72	T	PTN11_HUMAN	Disease (JMML)	121918453	A	A	72	T
20	UniProt	VAR_015997	A	72	V	PTN11_HUMAN	Disease (JMML)	121918454	A	A	72	V
21	UniProt	VAR_015609	T	73	I	PTN11_HUMAN	Disease (NS1)	28933387	A	T	73	I
22	UniProt	VAR_015998	E	76	A	PTN11_HUMAN	Disease (JMML)	121918465	A	E	76	A
23	UniProt	VAR_015610	E	76	D	PTN11_HUMAN	Disease (NS1)	397507514	A	E	76	D
24	UniProt	VAR_015999	E	76	G	PTN11_HUMAN	Disease (JMML)	121918465	A	E	76	G
25	UniProt	VAR_016000	E	76	K	PTN11_HUMAN	Disease (JMML)	28933388	A	E	76	K
26	UniProt	VAR_016001	E	76	V	PTN11_HUMAN	Disease (JMML)	121918465	A	E	76	V
27	UniProt	VAR_027186	Q	79	P	PTN11_HUMAN	Disease (NS1)	---	A	Q	79	P
28	UniProt	VAR_015611	Q	79	R	PTN11_HUMAN	Disease (NS1)	121918466	A	Q	79	R
29	UniProt	VAR_015612	D	106	A	PTN11_HUMAN	Disease (NS1)	397507517	A	D	106	A
30	UniProt	VAR_015613	E	139	D	PTN11_HUMAN	Disease (NS1)	397507520	A	E	139	D
31	UniProt	VAR_027187	Q	256	R	PTN11_HUMAN	Disease (NS1)	397507523	A	Q	256	R
32	UniProt	VAR_078101	L	261	F	PTN11_HUMAN	Disease (NS1)	397507525	A	L	261	F
33	UniProt	VAR_078102	L	261	H	PTN11_HUMAN	Disease (NS1)	765642157	A	L	261	H
34	UniProt	VAR_078103	L	262	F	PTN11_HUMAN	Disease (NS1)	---	A	L	262	F
35	UniProt	VAR_078104	L	262	R	PTN11_HUMAN	Disease (NS1)	397507526	A	L	262	R
36	UniProt	VAR_078105	R	265	Q	PTN11_HUMAN	Disease (NS1)	376607329	A	R	265	Q
37	UniProt	VAR_015614	Y	279	C	PTN11_HUMAN	Disease (NS1)	121918456	A	Y	279	C
38	UniProt	VAR_027188	Y	279	S	PTN11_HUMAN	Disease (LPRD1)	121918456	A	Y	279	S
39	UniProt	VAR_015615	I	282	V	PTN11_HUMAN	Disease (NS1)	397507529	A	I	282	V
40	UniProt	VAR_015617	F	285	L	PTN11_HUMAN	Disease (NS1)	397507531	A	F	285	L
41	UniProt	VAR_015616	F	285	S	PTN11_HUMAN	Disease (NS1)	121918463	A	F	285	S
42	UniProt	VAR_015619	N	308	D	PTN11_HUMAN	Disease (NS1)	28933386	A	N	308	D
43	UniProt	VAR_015618	N	308	S	PTN11_HUMAN	Disease (NS1)	121918455	A	N	308	S
44	UniProt	VAR_015620	I	309	V	PTN11_HUMAN	Unclassified (NS1)	201787206	A	I	309	V
45	UniProt	VAR_027189	T	415	M	PTN11_HUMAN	Disease (NS1)	121918467	A	T	411	M
46	UniProt	VAR_027190	A	465	T	PTN11_HUMAN	Disease (LPRD1)	121918468	A	A	461	T
47	UniProt	VAR_027191	G	468	A	PTN11_HUMAN	Disease (LPRD1)	121918469	A	G	464	A
48	UniProt	VAR_015621	T	472	M	PTN11_HUMAN	Disease (LPRD1)	121918457	A	T	468	M
49	UniProt	VAR_071706	P	495	S	PTN11_HUMAN	Disease (NS1)	397507539	A	P	491	S
50	UniProt	VAR_027192	R	502	L	PTN11_HUMAN	Disease (LPRD1)	397507542	A	R	498	L
51	UniProt	VAR_027193	R	502	W	PTN11_HUMAN	Disease (LPRD1)	397507541	A	R	498	W
52	UniProt	VAR_015622	R	505	K	PTN11_HUMAN	Disease (NS1)	397507543	A	R	501	K
53	UniProt	VAR_015623	S	506	T	PTN11_HUMAN	Disease (NS1)	121918458	A	S	502	T
54	UniProt	VAR_016002	G	507	A	PTN11_HUMAN	Disease (JMML)	397507546	A	G	503	A
55	UniProt	VAR_016003	G	507	R	PTN11_HUMAN	Disease (NS1)	397507545	A	G	503	R
56	UniProt	VAR_015624	M	508	V	PTN11_HUMAN	Disease (NS1)	397507547	A	M	504	V
57	UniProt	VAR_027194	Q	510	P	PTN11_HUMAN	Disease (LPRD1)	397509345	A	Q	506	P
58	UniProt	VAR_027195	Q	510	R	PTN11_HUMAN	Disease (NS1)	---	A	Q	506	R
59	UniProt	VAR_076499	Q	514	E	PTN11_HUMAN	Disease (NS1)	397507549	A	Q	510	E
60	UniProt	VAR_027196	Q	514	P	PTN11_HUMAN	Disease (LPRD1)	121918470	A	Q	510	P

SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)

Biological Unit 2 (60, 60)

								dbSNP	PDB
No.	Source	Variant ID	Variant			UniProt ID	Status	ID	Chain	Variant
01	UniProt	VAR_027183	T	2	I	PTN11_HUMAN	Disease (NS1)	267606990	B	K	2	I
02	UniProt	VAR_015601	T	42	A	PTN11_HUMAN	Disease (NS1)	397507501	B	T	42	A
03	UniProt	VAR_027184	N	58	K	PTN11_HUMAN	Disease (NS1)	397507506	B	N	58	K
04	UniProt	VAR_066060	T	59	A	PTN11_HUMAN	Disease (NS1)	---	B	T	59	A
05	UniProt	VAR_015602	G	60	A	PTN11_HUMAN	Disease (NS1)	397507509	B	G	60	A
06	UniProt	VAR_015990	G	60	V	PTN11_HUMAN	Polymorphism	397507509	B	G	60	V
07	UniProt	VAR_015603	D	61	G	PTN11_HUMAN	Disease (NS1)	121918461	B	D	61	G
08	UniProt	VAR_015604	D	61	N	PTN11_HUMAN	Disease (NS1)	397507510	B	D	61	N
09	UniProt	VAR_015991	D	61	V	PTN11_HUMAN	Disease (JMML)	121918461	B	D	61	V
10	UniProt	VAR_015992	D	61	Y	PTN11_HUMAN	Disease (JMML)	---	B	D	61	Y
11	UniProt	VAR_015605	Y	62	D	PTN11_HUMAN	Disease (NS1)	121918460	B	Y	62	D
12	UniProt	VAR_015606	Y	63	C	PTN11_HUMAN	Disease (NS1)	121918459	B	Y	63	C
13	UniProt	VAR_015993	E	69	K	PTN11_HUMAN	Disease (JMML)	---	B	E	69	K
14	UniProt	VAR_027185	E	69	Q	PTN11_HUMAN	Disease (NS1)	397507511	B	E	69	Q
15	UniProt	VAR_015994	F	71	K	PTN11_HUMAN	Unclassified	---	B	F	71	K
16	UniProt	VAR_015995	F	71	L	PTN11_HUMAN	Polymorphism	397507512	B	F	71	L
17	UniProt	VAR_015607	A	72	G	PTN11_HUMAN	Disease (NS1)	121918454	B	A	72	G
18	UniProt	VAR_015608	A	72	S	PTN11_HUMAN	Disease (NS1)	121918453	B	A	72	S
19	UniProt	VAR_015996	A	72	T	PTN11_HUMAN	Disease (JMML)	121918453	B	A	72	T
20	UniProt	VAR_015997	A	72	V	PTN11_HUMAN	Disease (JMML)	121918454	B	A	72	V
21	UniProt	VAR_015609	T	73	I	PTN11_HUMAN	Disease (NS1)	28933387	B	T	73	I
22	UniProt	VAR_015998	E	76	A	PTN11_HUMAN	Disease (JMML)	121918465	B	E	76	A
23	UniProt	VAR_015610	E	76	D	PTN11_HUMAN	Disease (NS1)	397507514	B	E	76	D
24	UniProt	VAR_015999	E	76	G	PTN11_HUMAN	Disease (JMML)	121918465	B	E	76	G
25	UniProt	VAR_016000	E	76	K	PTN11_HUMAN	Disease (JMML)	28933388	B	E	76	K
26	UniProt	VAR_016001	E	76	V	PTN11_HUMAN	Disease (JMML)	121918465	B	E	76	V
27	UniProt	VAR_027186	Q	79	P	PTN11_HUMAN	Disease (NS1)	---	B	Q	79	P
28	UniProt	VAR_015611	Q	79	R	PTN11_HUMAN	Disease (NS1)	121918466	B	Q	79	R
29	UniProt	VAR_015612	D	106	A	PTN11_HUMAN	Disease (NS1)	397507517	B	D	106	A
30	UniProt	VAR_015613	E	139	D	PTN11_HUMAN	Disease (NS1)	397507520	B	E	139	D
31	UniProt	VAR_027187	Q	256	R	PTN11_HUMAN	Disease (NS1)	397507523	B	Q	256	R
32	UniProt	VAR_078101	L	261	F	PTN11_HUMAN	Disease (NS1)	397507525	B	L	261	F
33	UniProt	VAR_078102	L	261	H	PTN11_HUMAN	Disease (NS1)	765642157	B	L	261	H
34	UniProt	VAR_078103	L	262	F	PTN11_HUMAN	Disease (NS1)	---	B	L	262	F
35	UniProt	VAR_078104	L	262	R	PTN11_HUMAN	Disease (NS1)	397507526	B	L	262	R
36	UniProt	VAR_078105	R	265	Q	PTN11_HUMAN	Disease (NS1)	376607329	B	R	265	Q
37	UniProt	VAR_015614	Y	279	C	PTN11_HUMAN	Disease (NS1)	121918456	B	Y	279	C
38	UniProt	VAR_027188	Y	279	S	PTN11_HUMAN	Disease (LPRD1)	121918456	B	Y	279	S
39	UniProt	VAR_015615	I	282	V	PTN11_HUMAN	Disease (NS1)	397507529	B	I	282	V
40	UniProt	VAR_015617	F	285	L	PTN11_HUMAN	Disease (NS1)	397507531	B	F	285	L
41	UniProt	VAR_015616	F	285	S	PTN11_HUMAN	Disease (NS1)	121918463	B	F	285	S
42	UniProt	VAR_015619	N	308	D	PTN11_HUMAN	Disease (NS1)	28933386	B	N	308	D
43	UniProt	VAR_015618	N	308	S	PTN11_HUMAN	Disease (NS1)	121918455	B	N	308	S
44	UniProt	VAR_015620	I	309	V	PTN11_HUMAN	Unclassified (NS1)	201787206	B	I	309	V
45	UniProt	VAR_027189	T	415	M	PTN11_HUMAN	Disease (NS1)	121918467	B	T	411	M
46	UniProt	VAR_027190	A	465	T	PTN11_HUMAN	Disease (LPRD1)	121918468	B	A	461	T
47	UniProt	VAR_027191	G	468	A	PTN11_HUMAN	Disease (LPRD1)	121918469	B	G	464	A
48	UniProt	VAR_015621	T	472	M	PTN11_HUMAN	Disease (LPRD1)	121918457	B	T	468	M
49	UniProt	VAR_071706	P	495	S	PTN11_HUMAN	Disease (NS1)	397507539	B	P	491	S
50	UniProt	VAR_027192	R	502	L	PTN11_HUMAN	Disease (LPRD1)	397507542	B	R	498	L
51	UniProt	VAR_027193	R	502	W	PTN11_HUMAN	Disease (LPRD1)	397507541	B	R	498	W
52	UniProt	VAR_015622	R	505	K	PTN11_HUMAN	Disease (NS1)	397507543	B	R	501	K
53	UniProt	VAR_015623	S	506	T	PTN11_HUMAN	Disease (NS1)	121918458	B	S	502	T
54	UniProt	VAR_016002	G	507	A	PTN11_HUMAN	Disease (JMML)	397507546	B	G	503	A
55	UniProt	VAR_016003	G	507	R	PTN11_HUMAN	Disease (NS1)	397507545	B	G	503	R
56	UniProt	VAR_015624	M	508	V	PTN11_HUMAN	Disease (NS1)	397507547	B	M	504	V
57	UniProt	VAR_027194	Q	510	P	PTN11_HUMAN	Disease (LPRD1)	397509345	B	Q	506	P
58	UniProt	VAR_027195	Q	510	R	PTN11_HUMAN	Disease (NS1)	---	B	Q	506	R
59	UniProt	VAR_076499	Q	514	E	PTN11_HUMAN	Disease (NS1)	397507549	B	Q	510	E
60	UniProt	VAR_027196	Q	514	P	PTN11_HUMAN	Disease (LPRD1)	121918470	B	Q	510	P

SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)

Asymmetric Unit (4, 10)

	PROSITE			UniProtKB		PDB
No.	ID	AC	Description	ID	Location	Count	Location
1	SH2	PS50001	Src homology 2 (SH2) domain profile.	PTN11_HUMAN	6-102 112-216	4	A:6-102 B:6-102 A:112-216 B:112-216
2	TYR_PHOSPHATASE_PTP	PS50055	PTP type protein phosphatase family profile.	PTN11_HUMAN	247-525	2	A:247-521 B:247-521
3	TYR_PHOSPHATASE_2	PS50056	Tyrosine specific protein phosphatases family profile.	PTN11_HUMAN	440-516	2	A:436-512 B:436-512
4	TYR_PHOSPHATASE_1	PS00383	Tyrosine specific protein phosphatases active site.	PTN11_HUMAN	461-471	2	A:457-467 B:457-467

Biological Unit 1 (4, 5)

	PROSITE			UniProtKB		PDB
No.	ID	AC	Description	ID	Location	Count	Location
1	SH2	PS50001	Src homology 2 (SH2) domain profile.	PTN11_HUMAN	6-102 112-216	2	A:6-102 - A:112-216 -
2	TYR_PHOSPHATASE_PTP	PS50055	PTP type protein phosphatase family profile.	PTN11_HUMAN	247-525	1	A:247-521 -
3	TYR_PHOSPHATASE_2	PS50056	Tyrosine specific protein phosphatases family profile.	PTN11_HUMAN	440-516	1	A:436-512 -
4	TYR_PHOSPHATASE_1	PS00383	Tyrosine specific protein phosphatases active site.	PTN11_HUMAN	461-471	1	A:457-467 -

Biological Unit 2 (4, 5)

	PROSITE			UniProtKB		PDB
No.	ID	AC	Description	ID	Location	Count	Location
1	SH2	PS50001	Src homology 2 (SH2) domain profile.	PTN11_HUMAN	6-102 112-216	2	- B:6-102 - B:112-216
2	TYR_PHOSPHATASE_PTP	PS50055	PTP type protein phosphatase family profile.	PTN11_HUMAN	247-525	1	- B:247-521
3	TYR_PHOSPHATASE_2	PS50056	Tyrosine specific protein phosphatases family profile.	PTN11_HUMAN	440-516	1	- B:436-512
4	TYR_PHOSPHATASE_1	PS00383	Tyrosine specific protein phosphatases active site.	PTN11_HUMAN	461-471	1	- B:457-467

(no "Exon" information available for 2SHP)

Asymmetric Unit

Reformat:	Number of residues per line = ('0' or empty: single-line sequence representation)
	Number of residues per labelling interval =
	UniProt sequence: complete aligned part

Show mapping:	SCOP domains	CATH domains	Pfam domains	Secondary structure (by author)
	SAPs(SNPs)	PROSITE motifs	Exons
	(details for a mapped element are shown in a popup box when the mouse pointer rests over it)

Chain A from PDB  Type:PROTEIN  Length:491
 aligned with PTN11_HUMAN | Q06124 from UniProtKB/Swiss-Prot  Length:597

    Alignment length:528
                                    11        21        31        41        51        61        71        81        91       101       111       121       131       141       151       161       171       181       191       201       211       221       231       241       251       261       271       281       291       301       311       321       331       341       351       361       371       381       391       401       411       421       431       441       451       461       471       481       491       501       511       521        
          PTN11_HUMAN     2 TSRRWFHPNITGVEAENLLLTRGVDGSFLARPSKSNPGDFTLSVRRNGAVTHIKIQNTGDYYDLYGGEKFATLAELVQYYMEHHGQLKEKNGDVIELKYPLNCADPTSERWFHGHLSGKEAEKLLTEKGKHGSFLVRESQSHPGDFVLSVRTGDDKGESNDGKSKVTHVMIRCQELKYDVGGGERFDSLTDLVEHYKKNPMVETLGTVLQLKQPLNTTRINAAEIESRVRELSKLAETTDKVKQGFWEEFETLQQQECKLLYSRKEGQRQENKNKNRYKNILPFDHTRVVLHDGDPNEPVSDYINANIIMPEFETKCNNSKPKKSYIATQGCLQNTVNDFWRMVFQENSRVIVMTTKEVERGKSKCVKYWPDEYALKEYGVMRVRNVKESAAHDYTLRELKLSKVGQALLQGNTERTVWQYHFRTWPDHGVPSDPGGVLDFLEEVHHKQESIMDAGPVVVHCSAGIGRTGTFIVIDILIDIIREKGVDCDIDVPKTIQMVRSQRSGMVQTEAQYRFIYMAVQHYIETL 529
               SCOP domains d2shpa2 A:2-110 Tyrosine phoshatase shp-2                                                                    d2shpa3 A:111-218 Tyrosine phoshatase shp-2                                                                 d2shpa1 A:219-525           Tyrosine phosphatase                                                                                                                                                                                                                                                                        SCOP domains
               CATH domains 2shpA01 A:2-109 SHC Adaptor Protein                                                                         2shpA02 A:110-215 SHC Adaptor Protein                                                                     2shpA03 A:216-525 Pr          otein tyrosine phosphatase superfamily                                                                                                                                                                                                                                                       CATH domains
               Pfam domains ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ Pfam domains
         Sec.struct. author ...........hhhhhhhhhhh.....eeeee......eeeeeeee..eeeeeeee................hhhhhhhhhh...................................hhhhhhhhhhh.....eeeee.......eeeeeee..-----.....eeeeeeeeee..eee.........hhhhhhhhhh.......................hhhhhhhhhhhh.----------.hhhhhhhhhhhhhhh....hhhh.hhhhhh..................-------.....eeeee.-----------..eeeee....hhhhhhhhhhhhh....eeee.....................eeee..eeeeeeeeee...eeeeeeeeee..----.....eeeeeeee...........hhhhhhhhhhhhhhhh.......eeee......hhhhhhhhhhhhhhhhhh.......hhhhhhhhh.........hhhhhhhhhhhhhhhh.. Sec.struct. author
             SAPs(SNPs) (1) I---------------------------------------A---------------KAAGDC-----K-KGI--A--P--------------------------A--------------------------------D--------------------------------------------------------------------------------------------------------------------R----FF--Q-------------C--V--L----------------------DV---------------------------------------------------------------------------------------------------------M-------------------------------------------------T--A---M----------------------S------L--KTAV-P---E--------------- SAPs(SNPs) (1)
             SAPs(SNPs) (2) ----------------------------------------------------------VN-------Q-LS---D--R-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------HR----------------S-----S----------------------S-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------W----R--R---P--------------- SAPs(SNPs) (2)
             SAPs(SNPs) (3) -----------------------------------------------------------V----------T---G--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- SAPs(SNPs) (3)
             SAPs(SNPs) (4) -----------------------------------------------------------Y----------V---K--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- SAPs(SNPs) (4)
             SAPs(SNPs) (5) --------------------------------------------------------------------------V--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- SAPs(SNPs) (5)
                PROSITE (1) ----SH2  PDB: A:6-102 UniProt: 6-102                                                                 ---------SH2  PDB: A:112-216 UniProt: 112-216                                                                     ------------------------------TYR_PHOSPHATASE_PTP  PDB: A:247-521 UniProt: 247-525                                                                                                                                                                                                                                   ---- PROSITE (1)
                PROSITE (2) ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------TYR_PHOSPHATASE_2  PDB: A:436-512 UniProt: 440-516                           ------------- PROSITE (2)
                PROSITE (3) ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------TYR_PHOSPHA---------------------------------------------------------- PROSITE (3)
                 Transcript ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ Transcript
                 2shp A   2 KSRRWFHPNITGVEAENLLLTRGVDGSFLARPSKSNPGDLTLSVRRNGAVTHIKIQNTGDYYDLYGGEKFATLAELVQYYMEHHGQLKEKNGDVIELKYPLNCADPTSERWFHGHLSGKEAEKLLTEKGKHGSFLVRESQSHPGDFVLSVRTGD-----NDGKSKVTHVMIRCQELKYDVGGGERFDSLTDLVEHYKKNPMVETLGTVLQLKQPLNTTRINAAEIESRVRELSK----------GFWEEFETLQQQECKLLYSRKEGQRQENKNKNRYKNILPFDHTRVVLHD-------SDYINANIIMP-----------KKSYIATQGCLQNTVNDFWRMVFQENSRVIVMTTKEVERGKSKCVKYWPDEYALKEYGVMRVRNVKESAAHDYTLRELKLSKVG----QGNTERTVWQYHFRTWPDHGVPSDPGGVLDFLEEVHHKQESIMDAGPVVVHCSAGIGRTGTFIVIDILIDIIREKGVDCDIDVPKTIQMVRSQRSGMVQTEAQYRSIYMAVQHYIETL 525
                                    11        21        31        41        51        61        71        81        91       101       111       121       131       141       151   |   161       171       181       191       201       211       221       231   |     -    |  251       261       271       281       291  |      -|      311|        -  |    331       341       351       361       371       381       391       401     |   -|      417       427       437       447       457       467       477       487       497       507       517        
                                                                                                                                                                                   155   161                                                                       235        246                                             294     302       312         324                                                                                407  408

Chain B from PDB  Type:PROTEIN  Length:491
 aligned with PTN11_HUMAN | Q06124 from UniProtKB/Swiss-Prot  Length:597

    Alignment length:528
                                    11        21        31        41        51        61        71        81        91       101       111       121       131       141       151       161       171       181       191       201       211       221       231       241       251       261       271       281       291       301       311       321       331       341       351       361       371       381       391       401       411       421       431       441       451       461       471       481       491       501       511       521        
          PTN11_HUMAN     2 TSRRWFHPNITGVEAENLLLTRGVDGSFLARPSKSNPGDFTLSVRRNGAVTHIKIQNTGDYYDLYGGEKFATLAELVQYYMEHHGQLKEKNGDVIELKYPLNCADPTSERWFHGHLSGKEAEKLLTEKGKHGSFLVRESQSHPGDFVLSVRTGDDKGESNDGKSKVTHVMIRCQELKYDVGGGERFDSLTDLVEHYKKNPMVETLGTVLQLKQPLNTTRINAAEIESRVRELSKLAETTDKVKQGFWEEFETLQQQECKLLYSRKEGQRQENKNKNRYKNILPFDHTRVVLHDGDPNEPVSDYINANIIMPEFETKCNNSKPKKSYIATQGCLQNTVNDFWRMVFQENSRVIVMTTKEVERGKSKCVKYWPDEYALKEYGVMRVRNVKESAAHDYTLRELKLSKVGQALLQGNTERTVWQYHFRTWPDHGVPSDPGGVLDFLEEVHHKQESIMDAGPVVVHCSAGIGRTGTFIVIDILIDIIREKGVDCDIDVPKTIQMVRSQRSGMVQTEAQYRFIYMAVQHYIETL 529
               SCOP domains d2shpb2 B:2-110 Tyrosine phoshatase shp-2                                                                    d2shpb3 B:111-218 Tyrosine phoshatase shp-2                                                                 d2shpb1 B:219-525           Tyrosine phosphatase                                                                                                                                                                                                                                                                        SCOP domains
               CATH domains 2shpB01 B:2-109 SHC Adaptor Protein                                                                         2shpB02 B:110-215 SHC Adaptor Protein                                                                     2shpB03 B:216-521 Pr          otein tyrosine phosphatase superfamily                                                                                                                                                                                                                                                  ---- CATH domains
           Pfam domains (1) --------------------------------------------------------------------------------------------------------------SH2-2shpB03 B:112-197                                                                 --------------------------------------          ---------------------------Y_phosphatase-2shpB01        B:273-520                                                                                                                                                                                                                      ----- Pfam domains (1)
           Pfam domains (2) --------------------------------------------------------------------------------------------------------------SH2-2shpB04 B:112-197                                                                 --------------------------------------          ---------------------------Y_phosphatase-2shpB02        B:273-520                                                                                                                                                                                                                      ----- Pfam domains (2)
           Pfam domains (3) --------------------------------------------------------------------------------------------------------------SH2-2shpB05 B:112-197                                                                 --------------------------------------          -------------------------------------------------       -----------           ------------------------------------------------------------------------------------    ---------------------------------------------------------------------------------------------------------------------- Pfam domains (3)
           Pfam domains (4) --------------------------------------------------------------------------------------------------------------SH2-2shpB06 B:112-197                                                                 --------------------------------------          -------------------------------------------------       -----------           ------------------------------------------------------------------------------------    ---------------------------------------------------------------------------------------------------------------------- Pfam domains (4)
         Sec.struct. author ...........hhhhhhhhhhh.....eeeee......eeeeeeee..eeeeeeee................hhhhhhhhhh...................................hhhhhhhhhhh.....eeeee.......eeeeeee..-----.....eeeeeeeeee..eee.........hhhhhhhhhh.......................hhhhhhhhhhhh.----------.hhhhhhhhhhhhhhh....hhhh.hhhhhh..................-------.....eeee..-----------...eeee.......hhhhhhhhhhh...eeee.....................eeee..eeeeeeeeee...eeeeeeeeee..----.....eeeeeeee...........hhhhhhhhhhhhhhhh.......eeee......hhhhhhhhhhhhhhhhhh.......hhhhhhhhh.........hhhhhhhhhhhhhhhh.. Sec.struct. author
             SAPs(SNPs) (1) I---------------------------------------A---------------KAAGDC-----K-KGI--A--P--------------------------A--------------------------------D--------------------------------------------------------------------------------------------------------------------R----FF--Q-------------C--V--L----------------------DV---------------------------------------------------------------------------------------------------------M-------------------------------------------------T--A---M----------------------S------L--KTAV-P---E--------------- SAPs(SNPs) (1)
             SAPs(SNPs) (2) ----------------------------------------------------------VN-------Q-LS---D--R-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------HR----------------S-----S----------------------S-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------W----R--R---P--------------- SAPs(SNPs) (2)
             SAPs(SNPs) (3) -----------------------------------------------------------V----------T---G--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- SAPs(SNPs) (3)
             SAPs(SNPs) (4) -----------------------------------------------------------Y----------V---K--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- SAPs(SNPs) (4)
             SAPs(SNPs) (5) --------------------------------------------------------------------------V--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- SAPs(SNPs) (5)
                PROSITE (1) ----SH2  PDB: B:6-102 UniProt: 6-102                                                                 ---------SH2  PDB: B:112-216 UniProt: 112-216                                                                     ------------------------------TYR_PHOSPHATASE_PTP  PDB: B:247-521 UniProt: 247-525                                                                                                                                                                                                                                   ---- PROSITE (1)
                PROSITE (2) ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------TYR_PHOSPHATASE_2  PDB: B:436-512 UniProt: 440-516                           ------------- PROSITE (2)
                PROSITE (3) ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------TYR_PHOSPHA---------------------------------------------------------- PROSITE (3)
                 Transcript ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ Transcript
                 2shp B   2 KSRRWFHPNITGVEAENLLLTRGVDGSFLARPSKSNPGDLTLSVRRNGAVTHIKIQNTGDYYDLYGGEKFATLAELVQYYMEHHGQLKEKNGDVIELKYPLNCADPTSERWFHGHLSGKEAEKLLTEKGKHGSFLVRESQSHPGDFVLSVRTGD-----NDGKSKVTHVMIRCQELKYDVGGGERFDSLTDLVEHYKKNPMVETLGTVLQLKQPLNTTRINAAEIESRVRELSK----------GFWEEFETLQQQECKLLYSRKEGQRQENKNKNRYKNILPFDHTRVVLHD-------SDYINANIIMP-----------KKSYIATQGCLQNTVNDFWRMVFQENSRVIVMTTKEVERGKSKCVKYWPDEYALKEYGVMRVRNVKESAAHDYTLRELKLSKVG----QGNTERTVWQYHFRTWPDHGVPSDPGGVLDFLEEVHHKQESIMDAGPVVVHCSAGIGRTGTFIVIDILIDIIREKGVDCDIDVPKTIQMVRSQRSGMVQTEAQYRSIYMAVQHYIETL 525
                                    11        21        31        41        51        61        71        81        91       101       111       121       131       141       151   |   161       171       181       191       201       211       221       231   |     -    |  251       261       271       281       291  |      -|      311|        -  |    331       341       351       361       371       381       391       401     |   -|      417       427       437       447       457       467       477       487       497       507       517        
                                                                                                                                                                                   155   161                                                                       235        246                                             294     302       312         324                                                                                407  408

Legend:		→ Mismatch	(orange background)
	-	→ Gap	(green background, '-', border residues have a numbering label)
		→ Modified Residue	(blue background, lower-case, 'x' indicates undefined single-letter code, labelled with number + name)
	x	→ Chemical Group	(purple background, 'x', labelled with number + name, e.g. ACE or NH2)
	extra numbering lines below/above indicate numbering irregularities and modified residue names etc., number ends below/above '\|'

Asymmetric Unit

Classes(

)

Architectures( (-)

)

Topologies( (-)

)

Homologous Superfamilies( (-)

)

Organisms( (-)

)

Class: Alpha Beta (26913)

Architecture: 2-Layer Sandwich (8480)

Topology: SHC Adaptor Protein (206)

Homologous Superfamily: SHC Adaptor Protein (206)

Human (Homo sapiens) (147)

1a	2shpA02	A:110-215
1b	2shpB02	B:110-215
1c	2shpA01	A:2-109
1d	2shpB01	B:2-109

Architecture: Alpha-Beta Complex (3881)

Topology: Protein-Tyrosine Phosphatase; Chain A (262)

Homologous Superfamily: Protein tyrosine phosphatase superfamily (228)

Human (Homo sapiens) (196)

2a	2shpB03	B:216-521
2b	2shpA03	A:216-525

Asymmetric Unit

Clans(

)

Families(

)

Organisms( (-)

)

Clan: Phosphatase (121)

Family: Y_phosphatase (93)

Homo sapiens (Human) (82)

1a	Y_phosphatase-2shpB01	B:273-520
1b	Y_phosphatase-2shpB02	B:273-520

Clan: no clan defined [family: SH2] (119)

Family: SH2 (119)

Homo sapiens (Human) (79)

2a	SH2-2shpB03	B:112-197
2b	SH2-2shpB04	B:112-197
2c	SH2-2shpB05	B:112-197
2d	SH2-2shpB06	B:112-197

Asymmetric Unit(hide GO term definitions)

Chain A,B (PTN11_HUMAN | Q06124)

molecular function
	GO:0016303	1-phosphatidylinositol-3-kinase activity	Catalysis of the reaction: 1-phosphatidyl-1D-myo-inositol + ATP = a 1-phosphatidyl-1D-myo-inositol 3-phosphate + ADP + 2 H(+).
	GO:0031748	D1 dopamine receptor binding	Interacting selectively and non-covalently with a D1 dopamine receptor.
	GO:0005070	SH3/SH2 adaptor activity	Interacting selectively and non-covalently and simultaneously with one or more signal transduction molecules, usually acting as a scaffold to bring these molecules into close proximity either using their own SH2/SH3 domains (e.g. Grb2) or those of their target molecules (e.g. SAM68).
	GO:0016787	hydrolase activity	Catalysis of the hydrolysis of various bonds, e.g. C-O, C-N, C-C, phosphoric anhydride bonds, etc. Hydrolase is the systematic name for any enzyme of EC class 3.
	GO:0005158	insulin receptor binding	Interacting selectively and non-covalently with the insulin receptor.
	GO:0043560	insulin receptor substrate binding	Interacting selectively and non-covalently with any of the insulin receptor substrate (IRS) proteins, adaptor proteins that bind to the transphosphorylated insulin and insulin-like growth factor receptors, are themselves phosphorylated and in turn recruit SH2 domain-containing signaling molecules to form a productive signaling complex.
	GO:0004726	non-membrane spanning protein tyrosine phosphatase activity	Catalysis of the reaction: non-membrane spanning protein tyrosine phosphate + H2O = non-membrane spanning protein tyrosine + phosphate.
	GO:0051428	peptide hormone receptor binding	Interacting selectively and non-covalently with a receptor for peptide hormones.
	GO:0016791	phosphatase activity	Catalysis of the hydrolysis of phosphoric monoesters, releasing inorganic phosphate.
	GO:0046934	phosphatidylinositol-4,5-bisphosphate 3-kinase activity	Catalysis of the reaction: 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate + ATP = a 1-phosphatidyl-1D-myo-inositol 3,4,5-trisphosphate + ADP + 2 H(+).
	GO:0043274	phospholipase binding	Interacting selectively and non-covalently with any phospholipase, enzymes that catalyze of the hydrolysis of a glycerophospholipid.
	GO:0004721	phosphoprotein phosphatase activity	Catalysis of the reaction: a phosphoprotein + H2O = a protein + phosphate. Together with protein kinases, these enzymes control the state of phosphorylation of cell proteins and thereby provide an important mechanism for regulating cellular activity.
	GO:0005515	protein binding	Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
	GO:0019904	protein domain specific binding	Interacting selectively and non-covalently with a specific domain of a protein.
	GO:0004725	protein tyrosine phosphatase activity	Catalysis of the reaction: protein tyrosine phosphate + H2O = protein tyrosine + phosphate.
	GO:0030971	receptor tyrosine kinase binding	Interacting selectively and non-covalently with a receptor that possesses protein tyrosine kinase activity.
biological process
	GO:0060020	Bergmann glial cell differentiation	The process in which neuroepithelial cells of the neural tube give rise to Brgmann glial cells, specialized bipotential progenitors cells of the cerebellum. Differentiation includes the processes involved in commitment of a cell to a specific fate.
	GO:0000077	DNA damage checkpoint	A cell cycle checkpoint that regulates progression through the cell cycle in response to DNA damage. A DNA damage checkpoint may blocks cell cycle progression (in G1, G2 or metaphase) or slow the rate at which S phase proceeds.
	GO:0038127	ERBB signaling pathway	A series of molecular signals initiated by binding of a ligand to a member of the ERBB family of receptor tyrosine kinases on the surface of a cell, and ending with regulation of a downstream cellular process, e.g. transcription.
	GO:0031295	T cell costimulation	The process of providing, via surface-bound receptor-ligand pairs, a second, antigen-independent, signal in addition to that provided by the T cell receptor to augment T cell activation.
	GO:0033277	abortive mitotic cell cycle	A cell cycle in which mitosis is begun and progresses normally through the end of anaphase, but not completed, resulting in a cell with increased ploidy.
	GO:0000187	activation of MAPK activity	The initiation of the activity of the inactive enzyme MAP kinase (MAPK).
	GO:0036302	atrioventricular canal development	The progression of the atrioventricular canal over time, from its formation to the mature structure. The atrioventricular canal is the part of the heart connecting the atrium to the cardiac ventricle.
	GO:0007409	axonogenesis	De novo generation of a long process of a neuron, that carries efferent (outgoing) action potentials from the cell body towards target cells. Refers to the morphogenesis or creation of shape or form of the developing axon.
	GO:0007420	brain development	The process whose specific outcome is the progression of the brain over time, from its formation to the mature structure. Brain development begins with patterning events in the neural tube and ends with the mature structure that is the center of thought and emotion. The brain is responsible for the coordination and control of bodily activities and the interpretation of information from the senses (sight, hearing, smell, etc.).
	GO:0021697	cerebellar cortex formation	The process that gives rise to the cerebellar cortex. This process pertains to the initial formation of a structure from unspecified parts. The cerebellar cortex is a thin mantle of gray matter that covers the surface of each cerebral hemisphere. It has a characteristic morphology with convolutions (gyri) and crevices (sulci) that have specific functions. Six layers of nerve cells and the nerve pathways that connect them comprise the cerebellar cortex. Together, these regions are responsible for the processes of conscious thought, perception, emotion and memory as well as advanced motor function.
	GO:0016311	dephosphorylation	The process of removing one or more phosphoric (ester or anhydride) residues from a molecule.
	GO:0048013	ephrin receptor signaling pathway	The series of molecular signals generated as a consequence of an ephrin receptor binding to an ephrin.
	GO:0007173	epidermal growth factor receptor signaling pathway	A series of molecular signals initiated by binding of a ligand to the tyrosine kinase receptor EGFR (ERBB1) on the surface of a cell. The pathway ends with regulation of a downstream cellular process, e.g. transcription.
	GO:0060325	face morphogenesis	The process in which the anatomical structures of the face are generated and organized. The face is the ventral division of the head.
	GO:0008543	fibroblast growth factor receptor signaling pathway	The series of molecular signals generated as a consequence of a fibroblast growth factor receptor binding to one of its physiological ligands.
	GO:0048806	genitalia development	The process whose specific outcome is the progression of the genitalia over time, from its formation to the mature structure.
	GO:0042593	glucose homeostasis	Any process involved in the maintenance of an internal steady state of glucose within an organism or cell.
	GO:0007507	heart development	The process whose specific outcome is the progression of the heart over time, from its formation to the mature structure. The heart is a hollow, muscular organ, which, by contracting rhythmically, keeps up the circulation of the blood.
	GO:0048873	homeostasis of number of cells within a tissue	Any biological process involved in the maintenance of the steady-state number of cells within a population of cells in a tissue.
	GO:0042445	hormone metabolic process	The chemical reactions and pathways involving any hormone, naturally occurring substances secreted by specialized cells that affects the metabolism or behavior of other cells possessing functional receptors for the hormone.
	GO:0009755	hormone-mediated signaling pathway	A series of molecular signals mediated by the detection of a hormone.
	GO:0048839	inner ear development	The process whose specific outcome is the progression of the inner ear over time, from its formation to the mature structure.
	GO:0007229	integrin-mediated signaling pathway	A series of molecular signals initiated by the binding of extracellular ligand to an integrin on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription.
	GO:0061582	intestinal epithelial cell migration	The orderly movement of an intestinal epithelial cell from one site to another, often during the development of a multicellular organism.
	GO:0050900	leukocyte migration	The movement of a leukocyte within or between different tissues and organs of the body.
	GO:0006629	lipid metabolic process	The chemical reactions and pathways involving lipids, compounds soluble in an organic solvent but not, or sparingly, in an aqueous solvent. Includes fatty acids; neutral fats, other fatty-acid esters, and soaps; long-chain (fatty) alcohols and waxes; sphingoids and other long-chain bases; glycolipids, phospholipids and sphingolipids; and carotenes, polyprenols, sterols, terpenes and other isoprenoids.
	GO:0035855	megakaryocyte development	The process whose specific outcome is the progression of a megakaryocyte cell over time, from its formation to the mature structure. Megakaryocyte development does not include the steps involved in committing a cell to a megakaryocyte fate. A megakaryocyte is a giant cell 50 to 100 micron in diameter, with a greatly lobulated nucleus, found in the bone marrow.
	GO:0032528	microvillus organization	A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of a microvillus, a thin cylindrical membrane-covered projection on the surface of a cell.
	GO:0035264	multicellular organism growth	The increase in size or mass of an entire multicellular organism, as opposed to cell growth.
	GO:0048609	multicellular organismal reproductive process	The process, occurring above the cellular level, that is pertinent to the reproductive function of a multicellular organism. This includes the integrated processes at the level of tissues and organs.
	GO:0033629	negative regulation of cell adhesion mediated by integrin	Any process that stops, prevents, or reduces the frequency, rate, or extent of cell adhesion mediated by integrin.
	GO:0051463	negative regulation of cortisol secretion	Any process that stops, prevents, or reduces the frequency, rate or extent of the regulated release of cortisol from a cell.
	GO:0060125	negative regulation of growth hormone secretion	Any process that decreases or stops the frequency, rate or extent of the regulated release of growth hormone from a cell.
	GO:0046888	negative regulation of hormone secretion	Any process that stops, prevents, or reduces the frequency, rate or extent of the regulated release of a hormone from a cell.
	GO:0046676	negative regulation of insulin secretion	Any process that stops, prevents, or reduces the frequency, rate or extent of the regulated release of insulin.
	GO:0048011	neurotrophin TRK receptor signaling pathway	A series of molecular signals initiated by the binding of a neurotrophin to a receptor on the surface of the target cell where the receptor possesses tyrosine kinase activity, and ending with regulation of a downstream cellular process, e.g. transcription.
	GO:0035265	organ growth	The increase in size or mass of an organ. Organs are commonly observed as visibly distinct structures, but may also exist as loosely associated clusters of cells that function together as to perform a specific function.
	GO:0035335	peptidyl-tyrosine dephosphorylation	The removal of phosphoric residues from peptidyl-O-phospho-tyrosine to form peptidyl-tyrosine.
	GO:0046854	phosphatidylinositol phosphorylation	The process of introducing one or more phosphate groups into a phosphatidylinositol, any glycerophosphoinositol having one phosphatidyl group esterified to one of the hydroxy groups of inositol.
	GO:0036092	phosphatidylinositol-3-phosphate biosynthetic process	The chemical reactions and pathways resulting in the formation of phosphatidylinositol-3-phosphate, a phosphatidylinositol monophosphate carrying the phosphate group at the 3-position.
	GO:0048015	phosphatidylinositol-mediated signaling	A series of molecular signals in which a cell uses a phosphatidylinositol-mediated signaling to convert a signal into a response. Phosphatidylinositols include phosphatidylinositol (PtdIns) and its phosphorylated derivatives.
	GO:0030168	platelet activation	A series of progressive, overlapping events triggered by exposure of the platelets to subendothelial tissue. These events include shape change, adhesiveness, aggregation, and release reactions. When carried through to completion, these events lead to the formation of a stable hemostatic plug.
	GO:0030220	platelet formation	The process in which platelets bud from long processes extended by megakaryocytes.
	GO:0048008	platelet-derived growth factor receptor signaling pathway	The series of molecular signals generated as a consequence of a platelet-derived growth factor receptor binding to one of its physiological ligands.
	GO:0070374	positive regulation of ERK1 and ERK2 cascade	Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the ERK1 and ERK2 cascade.
	GO:2001275	positive regulation of glucose import in response to insulin stimulus	Any process that activates or increases the frequency, rate or extent of glucose import in response to insulin stimulus.
	GO:0046887	positive regulation of hormone secretion	Any process that activates or increases the frequency, rate or extent of the regulated release of a hormone from a cell.
	GO:0045931	positive regulation of mitotic cell cycle	Any process that activates or increases the rate or extent of progression through the mitotic cell cycle.
	GO:0009967	positive regulation of signal transduction	Any process that activates or increases the frequency, rate or extent of signal transduction.
	GO:0006470	protein dephosphorylation	The process of removing one or more phosphoric residues from a protein.
	GO:0033628	regulation of cell adhesion mediated by integrin	Any process that modulates the frequency, rate, or extent of cell adhesion mediated by integrin.
	GO:0040014	regulation of multicellular organism growth	Any process that modulates the frequency, rate or extent of growth of the body of an organism so that it reaches its usual body size.
	GO:0014066	regulation of phosphatidylinositol 3-kinase signaling	Any process that modulates the frequency, rate or extent of signal transduction mediated by the phosphatidylinositol 3-kinase cascade.
	GO:0043254	regulation of protein complex assembly	Any process that modulates the frequency, rate or extent of protein complex assembly.
	GO:0046825	regulation of protein export from nucleus	Any process that modulates the frequency, rate or extent of the directed movement of proteins from the nucleus to the cytoplasm.
	GO:0060338	regulation of type I interferon-mediated signaling pathway	Any process that modulates the rate, frequency or extent of a type I interferon-mediated signaling pathway. A type I interferon-mediated signaling pathway is the series of molecular events generated as a consequence of a type I interferon binding to a cell surface receptor.
	GO:0006641	triglyceride metabolic process	The chemical reactions and pathways involving triglyceride, any triester of glycerol. The three fatty acid residues may all be the same or differ in any permutation. Triglycerides are important components of plant oils, animal fats and animal plasma lipoproteins.
cellular component
	GO:0005737	cytoplasm	All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
	GO:0005829	cytosol	The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
	GO:0005739	mitochondrion	A semiautonomous, self replicating organelle that occurs in varying numbers, shapes, and sizes in the cytoplasm of virtually all eukaryotic cells. It is notably the site of tissue respiration.
	GO:0005634	nucleus	A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
	GO:0043234	protein complex	A stable macromolecular complex composed (only) of two or more polypeptide subunits along with any covalently attached molecules (such as lipid anchors or oligosaccharide) or non-protein prosthetic groups (such as nucleotides or metal ions). Prosthetic group in this context refers to a tightly bound cofactor. The component polypeptide subunits may be identical.

Asymmetric Unit
	Complete Structure
		Jena3D(integrated viewing of ligand, site, SAP, PROSITE, SCOP information)
		WebMol \| AstexViewer[tm]@PDBe (Java Applets, require no local installation except for Java; loading may be slow)
		STRAP (Java WebStart application, automatic local installation, requires Java; full application with system access!)
		RasMol (require local installation)
		Molscript (VRML) (requires installation of a VRML viewer; select preferred view via VRML and generate a mono or stereo PDF format file)

	Ligands, Modified Residues, Ions
		CAT	[ RasMol \| Jena3D ]	+environment [ RasMol \| Jena3D ]

	Sites
		AC1	[ RasMol ]	+environment [ RasMol ]
		AC2	[ RasMol ]	+environment [ RasMol ]

	Cis Peptide Bonds
(no "Cis Peptide Bonds" information available for 2shp)

Biological Units
	Complete Structure
		Biological Unit 1	[ Jena3D ]
		Biological Unit 2	[ Jena3D ]

Jmol
	protein: cartoon or spacefill or dots and stick; nucleic acid: cartoon and stick; ligands: spacefill; active site: stick [ Asym. Unit PNG format \| Asym. Unit - sites PNG format \| Biol. Unit 1 PNG format \| Biol. Unit 1 - sites PNG format \| Biol. Unit 2 PNG format ](automatic orientation, automatically generated)
Molscript
	protein, nucleic acid: cartoon; ligands: spacefill; active site: ball and stick [ mono PDF format \| stereo PDF format ](default orientation, automatically generated)

Access by PDB/NDB ID
	2shp
		Family and Domain Information	:	ProDom \| SYSTERS
		General Structural Information	:	GlycoscienceDB \| MMDB \| NDB \| OCA \| PDB \| PDBe \| PDBj \| PDBsum \| PDBWiki \| PQS \| PROTEOPEDIA
		Orientation in Membranes	:	OPM
		Protein Surface	:	SURFACE
		Secondary Structure	:	DSSP (structure derived) \| HSSP (homology derived)
		Structural Genomics	:	GeneCensus
		Structural Neighbours	:	CE \| VAST
		Structure Classification	:	CATH \| Dali \| SCOP
		Validation and Original Data	:	BMRB Data View \| BMRB Restraints Grid \| EDS \| PROCHECK \| RECOORD \| WHAT_CHECK

Access by UniProt ID/Accession number
	PTN11_HUMAN \| Q06124
		Comparative Protein Structure Models	:	ModBase
		Genomic Information	:	Ensembl
		Protein-protein Interaction	:	DIP
		Sequence, Family and Domain Information	:	InterPro \| Pfam \| SMART \| UniProtKB/SwissProt

Access by Enzyme Classificator (EC Number)
	3.1.3.48
		General Enzyme Information	:	BRENDA \| EC-PDB \| Enzyme \| IntEnz
		Pathway	:	KEGG \| MetaCyc

Access by Disease Identifier (MIM ID)
	151100
		Disease Information	:	OMIM
	163950
		Disease Information	:	OMIM
	607785
		Disease Information	:	OMIM

Access by GenAge ID
	0019
		Age Related Information	:	GenAge
	0163
		Age Related Information	:	GenAge

Access by PDB/NDB ID
		Domain Information	:	XDom
		Interatomic Contacts of Structural Units	:	CSU
		Ligand-protein Contacts	:	LPC
		Protein Cavities	:	castP
		Sequence and Secondary Structure	:	PDBCartoon
		Structure Alignment	:	STRAP(Java WebStart application, automatic local installation, requires Java; full application with system access!)
		Structure and Sequence Browser	:	STING

Access by UniProt ID/Accession number
	PTN11_HUMAN \| Q06124
		Protein Disorder Prediction	:	DisEMBL \| FoldIndex \| GLOBPLOT (for more information see DisProt)

(no "Related Entries Specified in the PDB File" available for 2SHP)

Description

Compounds

Structural Features

Chains, Units

Ligands, Modified Residues, Ions (1, 2)

Sites (2, 2)

SS Bonds (0, 0)

Cis Peptide Bonds (0, 0)

Sequence-Structure Mapping

SAPs(SNPs)/Variants (60, 120)

PROSITE Motifs (4, 10)

Exons (0, 0)

Sequences/Alignments

Classification and Annotation

SCOP Domains (2, 6)

CATH Domains (2, 6)

Pfam Domains (2, 6)

Gene Ontology (78, 78)

Visualization

Interactive Views

Still Images

Databases and Analysis Tools

Databases

Analysis Tools

Related Entries

Entries Sharing at Least One Protein Chain (UniProt ID)

Related Entries Specified in the PDB File